Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18346-18353
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18346
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18346
Figure 1 Immunohistochemistry for zinc finger protein 139, Bcl-2, Bax and caspase-3 in gastric cancer and tumor-adjacent tissues.
A: Positive ZNF139 expression in GC; B: Negative ZNF139 expression in GC; C: Positive ZNF139 expression in tumor-adjacent tissues; D: Negative ZNF139 expression in tumor-adjacent tissues; E: Positive Bcl-2 expression in GC; F: Negative Bcl-2 expression in GC; G: Positive Bcl-2 expression in tumor-adjacent tissues; H: Negative Bcl-2 expression in tumor-adjacent tissues; I: Positive Bax expression in GC; J: Negative Bax expression in GC; K: Positive Bax expression in tumor-adjacent tissues; L: Negative Bax expression in tumor-adjacent tissues; M: Positive caspase-3 expression in GC; N: Negative caspase-3 expression in GC; O: Positive caspase-3 expression in tumor-adjacent tissues; P: Negative caspase-3 expression in tumor-adjacent tissues; (magnification × 400). ZNF139: Zinc finger protein 139; GC: Gastric cancer.
- Citation: Li Y, Zhao Q, Fan LQ, Wang LL, Tan BB, Leng YL, Liu Y, Wang D. Zinc finger protein 139 expression in gastric cancer and its clinical significance. World J Gastroenterol 2014; 20(48): 18346-18353
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18346.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18346